Gentamicin-resistance determinants confer background-dependent hygromycin B resistance

M Kojic1, N Milojevic, B Vasiljevic

  • 1Institute of Molecular Genetics and Genetic Engineering, Belgrade, Yugoslavia.

Microbial Drug Resistance (Larchmont, N.Y.)
|November 24, 1999
PubMed

Insights

Aminoglycoside-producing Micromonospora exhibit unexpected resistance to hygromycin B. This resistance is dependent on the specific strain and resistance genes, suggesting a novel mechanism beyond typical aminoglycoside resistance pathways.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Antibiotic Resistance

Background:

  • Micromonospora strains producing aminoglycosides display resistance to similar antibiotics.
  • They are typically susceptible to aminoglycosides with different aminocyclitol substitutions.
  • Unexpectedly, these strains also showed resistance to hygromycin B, which has a distinct structure and mechanism of action.

Purpose of the Study:

  • To investigate the mechanism behind hygromycin B resistance in aminoglycoside-producing Micromonospora.
  • To determine if known aminoglycoside resistance genes confer hygromycin B resistance.
  • To explore the strain-dependent nature of this resistance.

Main Methods:

  • Cloning of resistance genes (sgm, grm) into heterologous hosts (Streptomyces lividans, E. coli).
  • Introduction of resistance genes into M. melanosporea.
  • Testing of transformants for resistance to various aminoglycosides, including hygromycin B.
  • Comparison of resistance gene expression across different bacterial backgrounds.

Main Results:

  • Cloned genes conferred expected aminoglycoside resistance in S. lividans and E. coli, but not hygromycin B resistance.
  • In M. melanosporea, the same genes conferred resistance to hygromycin B.
  • Only the kgm gene facilitated hygromycin B resistance, and only in the M. melanosporea background.
  • This highlights a strain-dependent expression of hygromycin B resistance.

Conclusions:

  • Aminoglycoside resistance in Micromonospora is not solely determined by the resistance genes but also by the host genetic background.
  • A novel mechanism for hygromycin B resistance exists in M. melanosporea, influenced by strain-specific factors.
  • Further research is needed to elucidate the precise mechanism of this background-dependent resistance.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...